“Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation - PubMed” https://t.co/IhhhecLqoR
”We observed a lower number of major bleedings with factor Xa inhibitors (apixaban, edoxaban,rivaroxaban) compared with warfarin (OR 0.80, 95% CI 0.72 to 0.90)” Keep in mind that there was significant heterogeneity in this analysis. #WarfarinVsNOAC https:/
#CochraneEvidence: Treatment with factor Xa inhibitors significantly reduced the number of strokes and systemic embolic events compared with warfarin in people with AF. https://t.co/PKlpd5HPKh
Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation. - PubMed - NCBI https://t.co/flng4z0Qnr
RT @FarmaMadridAP: (Cochrane) Warfarina versus Inhibidores del Factor Xa en la prevención del ictus y embolismo sistémico. Revisión sistemá…
RT @FarmaMadridAP: (Cochrane) Warfarina versus Inhibidores del Factor Xa en la prevención del ictus y embolismo sistémico. Revisión sistemá…
RT @FarmaMadridAP: (Cochrane) Warfarina versus Inhibidores del Factor Xa en la prevención del ictus y embolismo sistémico. Revisión sistemá…
RT @FarmaMadridAP: (Cochrane) Warfarina versus Inhibidores del Factor Xa en la prevención del ictus y embolismo sistémico. Revisión sistemá…
RT @FarmaMadridAP: (Cochrane) Warfarina versus Inhibidores del Factor Xa en la prevención del ictus y embolismo sistémico. Revisión sistemá…
Factor Xa inhibitors when compared with warfarin, reduced the number of strokes in people with AF. Factor Xa inhibitors also appeared to reduce the number of serious bleedings and the number of people dying from any cause compared with warfarin. ... https:
RT @FarmaMadridAP: (Cochrane) Warfarina versus Inhibidores del Factor Xa en la prevención del ictus y embolismo sistémico. Revisión sistemá…
The Cochrane Library Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation #ACOD #FA https://t.co/EjrsLTn0yn
(Cochrane) Warfarina versus Inhibidores del Factor Xa en la prevención del ictus y embolismo sistémico. Revisión sistemática https://t.co/s1T1qdUOmb https://t.co/5kJ2WPPN2R
Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation https://t.co/eoVwZU3X2N
#LectureDeLaSemaine Anti-vitamine K ou anti-Xa (AOD) dans la prévention des embolies chez les patients avec fibrillation auriculaire? https://t.co/G3NwmCa7IB
@Nicoco_G ça devrait venir aussi dans l'ACFA https://t.co/uSMgv0pQz3
Congrats to the majority i.e. the 15 of you who responded correctly - 50% reduction in odds. See: https://t.co/zs64WLOCAa @canvector @CAEP_Docs @MarcCarrier1 @CAEPResidents @ASH_hematology
RT @rincondesisifo: (Cochrane) Inhibidores directos del factor Xa vs cumarinas en la prevención de ACV en pac con FA https://t.co/VfYsqaNp2…
(Cochrane) Inhibidores directos del factor Xa vs cumarinas en la prevención de ACV en pac con FA https://t.co/VfYsqaNp2i https://t.co/MomTeIAviC
Comparing two types of blood-thinning drugs, factor Xa inhibitors and vitamin K antagonists… https://t.co/2YMZpDH57j
Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic… https://t.co/YIRw46E0mu